- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Aurobindo Pharma Ltd
Add to PortfolioARBP:IN
117.00 INR 1.55 1.34%As of 07:05:50 ET on 05/25/2012.
Snapshot for Aurobindo Pharma Ltd (ARBP)
| Open: | 116.40 | Day's Range: | 112.15 - 118.35 | Volume: | 1,631,883 | Bid: | 116.80 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 115.45 | 52wk Range: | 80.15 - 188.90 | 1-Yr Rtn: | -28.98% | Ask: | 117.00 |
Key Statistics for ARBP
| Current P/E Ratio (ttm) | 5.9776 |
|---|---|
| Estimated P/E (03/2012) | 10.6655 |
| Earnings Per Share (INR) (ttm) | 19.5731 |
| Est. EPS (INR) (03/2012) | 10.9700 |
| Est. PEG Ratio | 0.4035 |
| Market Cap (M INR) | 34,061.19 |
| Shares Outstanding (M) | 291.12 |
| Enterprise Value (M INR) (ttm) | 63,784.49 |
| Enterprise Value/EBITDA (ttm) | 8.81 |
| Price/Book (mrq) | 1.3932 |
| Price/Sale (ttm) | 0.7687 |
| Dividend Indicated Gross Yield | 0.8547 |
| Next Earnings Announcement | 05/29/2012 |
More ARBP Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ARBP
No data available.
Company Profile & Key Executives for ARBP
Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.
| P V Ramaprasad ReddyChairman | K Nithyananda ReddyManaging Director |
| Sudhir B SinghiChief Financial Officer | M SivakumaranExecutive Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page